SCHEMBL26794068

SCHEMBL26794068

O=C(O)CCCCCN1C(=O)/C(=C/c2c[nH]c3ccccc23)OC1=S

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 2/20 0.46
▸ CCNT1 O60563 1/20 0.44
▸ CDK9 P50750 1/20 0.44
▸ PIK3CA P42336 1/20 0.40
▸ MTOR P42345 1/20 0.40
▸ MAP3K5 Q99683 1/20 0.40
▸ PIM1 P11309 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MAPT P10636 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ BLM P54132 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29727849 1.00 FFAR1 (0.46) FFAR1CCNT1CDK9PIK3CAMTOR
SCHEMBL13236136 0.80 FFAR1 (0.71) FFAR1MAP3K5KDM4EMEN1KMT2A
SCHEMBL24518535 0.78 FFAR1 (0.56) FFAR1CCNT1CDK9MAP3K5KDM4E
SCHEMBL29727858 0.78 FFAR1 (0.56) FFAR1CCNT1CDK9MAP3K5KDM4E
SCHEMBL12417242 0.76 FFAR1 (0.64) FFAR1MAP3K5KDM4ENPC1RAB9A
SCHEMBL13780771 0.73 MMP1 (0.54) FFAR1NPC1RAB9AHPGDLMNA
SCHEMBL24518366 0.72 FFAR1 (0.43) FFAR1CCNT1CDK9MAP3K5KDM4E
SCHEMBL26794059 0.72 FFAR1 (0.59) FFAR1MAP3K5KDM4EMEN1KMT2A
SCHEMBL26794066 0.68 FFAR1 (0.58) FFAR1MAP3K5KDM4EMEN1KMT2A
SCHEMBL9920145 0.67 FFAR1 (0.53) FFAR1KDM4ERAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11820764-B2 Compound modulating GSK-3 activity NATIONAL INSTITUTE OF IMMUNOLOGY (IN) 2023-11-21 — — US disclosed
US-11820764-B2 Compound modulating GSK-3 activity NATIONAL INSTITUTE OF IMMUNOLOGY (IN) 2023-11-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11820764-B2 Compound modulating GSK-3 activity GSK3B, GSK3A, GSKIP FFAR1 3450/4885CCNT1 409/4885CDK9 102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback